Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
Espen Melum, Tom H. Karlsen, Erik Schrumpf, Annika Bergquist, Erik Thorsby, Kirsten M. Boberg, Benedicte A. Lie – 26 December 2007 – Primary sclerosing cholangitis (PSC) is often complicated by the development of cholangiocarcinoma (CCA). Genetic variation of natural killer cell receptor G2D (NKG2D) has been associated with cancer susceptibility. An important ligand for NKG2D, major histocompatibility complex class I chain‐related molecule A (MICA), serves as a marker of cellular stress. The 5.1 allele of the gene encoding MICA has been associated with PSC.